Sign in to confirm you’re not a bot
This helps protect our community. Learn more

ICBC Berlin 2022 B2B Conference Panels Day 2 | Cannabis In Biotechnology

International Cannabis Business Conference
1.12K subscribers
<__slot-el>
<__slot-el>
146 views 2 years ago
Cannabis and its ingredients are getting more and more relevance in pharmaceutical and biotechnology. Companies are not only looking for innovation in individual APIs, but also in novel delivery systems. Pharmaceutical companies are getting ready for the "road to finished medicines" and recently, more and more Pharma-Players have entered the market. What does the future of cannabinoids and other cannabis-derived active ingredients in life science industries hold? What kind of cutting-edge technologies and innovations are on the horizon? Is the Cannabinoid-API of the future made from real cannabis, or are these ingredients synthetically developed and sampled together in pharmaceutical laboratories across the globe? ...more
...more
ICBC Berlin 2022 B2B Conference Panels Day 2 | Cannabis In Biotechnology
1Likes
146Views
2022Jul 28
Cannabis and its ingredients are getting more and more relevance in pharmaceutical and biotechnology. Companies are not only looking for innovation in individual APIs, but also in novel delivery systems. Pharmaceutical companies are getting ready for the "road to finished medicines" and recently, more and more Pharma-Players have entered the market. What does the future of cannabinoids and other cannabis-derived active ingredients in life science industries hold? What kind of cutting-edge technologies and innovations are on the horizon? Is the Cannabinoid-API of the future made from real cannabis, or are these ingredients synthetically developed and sampled together in pharmaceutical laboratories across the globe?

Follow along using the transcript.

International Cannabis Business Conference

1.12K subscribers